Publications

Development of an RNA aptamer as a therapeutic agent for synucleinopathies

 9
Development of an RNA aptamer as a therapeutic agent for synucleinopathies

Tags:

Previous Article

Cognitive symptoms in cerebral palsy from remote network

Next Article

RNA aptamer to treat synucleinopathies

Related Posts

Targeting microbiota-generated acetaldehyde to prevent progression of metabolic dysfunction- associated steatotic liver disease

Targeting microbiota-generated acetaldehyde to prevent...

 59

Astrocyte fatty acid metabolism as a driver of risk for major depressive disorder

Astrocyte fatty acid metabolism as a driver of risk for...

 58

Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance

Cuproptosis-immunity crosstalk informs strategy to over...

 50